Goldman Sachs lead the Dow with a nearly 7% gain
The Dow Jones Industrial Average (DJI) is still riding high on bank earnings -- up over 140 points at midday. Goldman Sachs (GS), in particular, is leading the blue chips with a nearly 7% gain. Apple (AAPL) stock is also higher, amid reports the company is in talks with several private Medicare plans to distribute Apple Watches to seniors. Traders are also digesting the National Association of Home Builders (NAHB) index, which showed homebuilder sentiment rebounded last month amid sinking mortgage rates. Against this backdrop -- and ahead of a no-confidence vote for U.K. Prime Minister Theresa May -- the S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are both higher at midday.
Continue reading for more on today's market, including:
- The C-Suite shakeup sending this social media stock spiraling.
- Analysts expect this energy stock to double.
- Plus, SM Energy stock is garnering interest; the stock that's tripled on a Menards deal; and ATPX takes a huge hit.

SM Energy Co (NYSE:SM) is seeing notable options activity today. Calls are outnumbering puts, with 5,292 exchanging hands today -- roughly 64 times the average intraday pace. Meanwhile, the 3,727 puts traded is 29 times the average pace. The February 22.50 call and 17.50 put are the most popular, with Trade-Alert indicating that a single speculator sold the puts to buy the calls. At last check, SM stock is flat at $19.85, despite a new "overweight" rating and $27 price target at Barclays.
ToughBuilt Industries Inc (NASDAQ:TBLT) stock is the best on the Nasdaq today -- dramatically higher, and temporarily halted, after a formal announcement that the company would be launching product sales with the Menards home improvement chain. TBLT stock, which went public in early December, has more than tripled today, up 223.3% at $4.05, at last check. The shares earlier tapped a new record high of $5.55.
Aptinyx Inc (NASDAQ:APTX) is one of the worst performers on the Nasdaq today, after the pharma company's new treatment for diabetic nerve damage failed to meet its mid-stage goals. Prior to today, APTX was struggling to conquer its 20-day trendline. Today, however, the shares are pacing for their worst day ever -- down 70.6% at $5.25, at last check, and touching a new record low of $5.02 earlier.
